Antisecretory Factor–Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma
Shirin Ilkhanizadeh(University of California, San Francisco), Anders I. Persson(University of California, San Francisco), Mitchel S. Berger(University of California, San Francisco), Joanna J. Phillips(University of California, San Francisco), Edith Yuan(University of California, San Francisco), Valerie M. Weaver(University of California, San Francisco), Jason A. Burdick(University of Colorado Boulder), Janna K. Mouw(Emory University), Aaron Frantz(Sanford Burnham Prebys Medical Discovery Institute), David A. Quigley(Universidad Católica de Santa Fe), Dandan Sun(Anhui University of Traditional Chinese Medicine), Hanna Sabelström(University of California, San Francisco), Supna Saxena(UCSF Helen Diller Family Comprehensive Cancer Center), Christin Schmidt(University of California, San Francisco), Sergey Magnitsky(University of California, San Francisco), Jacqueline R. Trzeciak(University of California, San Francisco), William A. Weiss(City College of San Francisco), Aurora Idilli(University of Trento), Olle R. Lindberg(University of California, San Francisco), Yekaterina A. Miroshnikova(National Institutes of Health), Daniele Arosio(University of Trento), Trenten Fenster(University of California, San Francisco), Wen Zhu(University of Pittsburgh), Jon N. Lakins(University of California, San Francisco)
Cited by 21
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis
|Journal of Clinical Oncology|2012|1k
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
|BMC Medicine|2008|948
Mechanics, malignancy, and metastasis: The force journey of a tumor cell
|Cancer and Metastasis Reviews|2009|924
Targeted expression of MYCN causes neuroblastoma in transgenic mice
|The EMBO Journal|1997|870